STRS Ohio’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

STRS Ohio’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,900	Closed	-$114K	–	2535
2021 Q1	$114K	Hold	1,900	–	–	﹤0.01%	1920
2020 Q4	$28K	Hold	1,900	–	–	﹤0.01%	2058
2020 Q3	$21K	Buy	+1,900	New	+$32.5K	﹤0.01%	2090

STRS Ohio's PAND Position: Q2 2021 in Review

STRS Ohio sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 1,900 shares — an estimated $114K sold.

STRS Ohio first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $114K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

STRS Ohio reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
STRS Ohio sold 1,900 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $114K.
STRS Ohio first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
STRS Ohio's Pandion Therapeutics Inc. Common Stock position peaked at $114K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.